« Previous
Next »
Fertility and Sterility
Volume 89, Issue 2
, Pages 465-467
, February 2008
Soluble HLA-G in the peritoneal fluid of women with endometriosis
References
- . Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril. 1991;56:45–51
- . The natural killer activity of peritoneal fluid lumphocytes is decreased in women with endometriosis. Fertil Steril. 1992;58:290–295
- . Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest. 1992;34:2–30
- . Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil Steril. 1994;62:1086–1088
- . Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest. 1992;34:27–30
- . Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod. 1998;4:1150–1156
- . Interleukin-12 and its free p40 subunit regulate immune recognition of endometrial cells: potential role in endometriosis. J Clin Endocrinol Metabol. 1998;83:911–916
- . Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis. Fertil Steril. 2002;78:855–859
- Apoptosis in human endometrium and endometriosis. Hum Reprod Update. 2004;10:29–38
- Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res. 1998;58:1741–1749
- . Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J Clin Endocrinol Metabol. 1999;84:2188–2194
- . The putative role of cell adhesion molecules in endometriosis; can we learn from tumour metastasis?. Mol Med Today. 1999;5:304–309
- . Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted. Neoplasma. 2000;47:342–348
- . HLA-G expression by tumors. Am J Reprod Immunol. 2001;45:103–107
- . HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol. 2002;26:914–920
- . Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol. 2003;13:371–377
- Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J Pathol. 2002;196:266–274
- . HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood. 2002;99:609–617
- . Revised classification of endometriosis. Fertil Steril. 1997;67:817–821
- . Histocompatibility leukocyte antigen-G is not expressed by endometriosis or endometrial tissue. Fertil Steril. 2001;75:814–817
- . HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium. Hum Reprod. 2006;21:864–869
- Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol. 2000;164:6100–6104
- A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc. 2001;33:2355–2359
- . HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology. 2000;101:191–200
- . HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol. 2001;166:5018–5026
- . HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol. 2000;48:17–26
- Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood. Am J Reprod Immunol. 2001;45:94–99
- . Expression of inhibitory-motif killer immunoglobulin-like receptor, KIR2DL1, is increased in natural killer cells from women with pelvic endometriosis. Am J Reprod Immunol. 2005;53:249–254
Supported by the Lithuanian Study and Science Foundation.
PII: S0015-0282(07)00506-7
doi: 10.1016/j.fertnstert.2007.02.036
© 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 89, Issue 2
, Pages 465-467
, February 2008

